CAR-Hematotox Score Predicts Toxicity, Infection & Clinical Outcomes in MCL
Patients with relapsed or refractory mantle cell lymphoma (MCL) and a high CAR-hematotox score had...
Dec 19, 2022
Patients with relapsed or refractory mantle cell lymphoma (MCL) and a high CAR-hematotox score had...
Dec 16, 2022
Metabolic tumor volume (MTV) was reported at the 2022 annual meeting of the American Society of...
Dec 15, 2022
Odronextamab, an investigational bi-specific antibody targeting CD20 and CD3, showed promising...
Dec 15, 2022
Consolidation high-dose chemotherapy followed by autologous stem cell transplantation (HCT/ASCT)...
Dec 15, 2022
In patients with previously untreated mantle cell lymphoma (MCL), autologous stem cell...
Dec 6, 2022
Friday, December 9th 7:00 a.m.– 6:00 p.m. Registration open (for in-person participants) 7:00 a.m. – 10:00 a.m. Friday Satellite Symposia 9:00 a.m. – 12:00 Training Program Directors’ Workshop 11:00 a.m. – 2:00 p.m. Friday...
Dec 6, 2022
Key Protocols: Vaccination will be required for all in-person meeting attendees. ASH is offering complimentary* medical evacuation and quarantine support coverage. Proof of a negative COVID-19 test is not required for in-person...
Dec 6, 2022
The ASH Foundation Run & Walk will start and finish on Convention Center Boulevard and Julia Street, head toward the Riverwalk near the Audubon Aquarium of the Americas, and go through Woldenberg Park. Schedule: 7:00 a.m....
Dec 6, 2022
FSS are industry-supported, CME-certified symposia. These sessions are not part of the official ASH annual meeting program and are planned solely by the sponsoring company. Morning Topics: A Thread To Pull: Unraveling The...
Nov 30, 2022
African American (AA) patients with diffuse large b-cell lymphoma (DLBCL) experience differences...
Nov 29, 2022
The most prevalent B-cell non-Hodgkin lymphoma is diffuse large B-cell lymphoma (DLBCL). Various...
Nov 28, 2022
A number of CD19-targeted medicines, such as chimeric antigen receptor T-cell therapy (CAR-T),...